An engineered palivizumab IgG2 subclass for synthetic gp130 and fas-mediated signaling - Christoph Wittich; Julia Ettich; Marcel Hertell; Biswadeep Ghosh Roy; Haifeng C. Xu; Doreen M. Floss; Philipp A. Lang; Jürgen Scheller (Journal of Biological Chemistry, 2025)